ADT in Combination with Radiation Therapy for Clinically Localized Prostate Cancer
Publisher
Springer Singapore
Reference40 articles.
1. Viani GA, Stefano EJ, Afonso SL. Higher-than-conventional radiation doses in localized prostate cancer treatment: a meta-analysis of randomized, controlled trials. Int J Radiat Oncol Biol Phys. 2009;74(5):1405–18.
https://doi.org/10.1016/j.ijrobp.2008.10.091
.
2. Zaorsky NG, Palmer JD, Hurwitz MD, Keith SW, Dicker AP, Den RB. What is the ideal radiotherapy dose to treat prostate cancer? A meta-analysis of biologically equivalent dose escalation. Radiother Oncol. 2015;115(3):295–300.
https://doi.org/10.1016/j.radonc.2015.05.011
.
3. Michalski M, Purd JA, Bosch WR, Bahary J, Lau H, Duclos M, et al. Initial results of a phase 3 randomized study of high dose 3DCRT/IMRT versus standard dose 3D–CRT/IMRT in patients treated for localized prostate cancer (RTOG 0126). Int J Radiat Oncol Biol Phys. 2014;90(5 Suppl 1):1263.
4. Hou Z, Li G, Bai S. High dose versus conventional dose in external beam radiotherapy of prostate cancer: a meta-analysis of long-term follow-up. J Cancer Res Clin Oncol. 2015;141(6):1063–71.
https://doi.org/10.1007/s00432-014-1813-1
.
5. Shipley WU, Desilvio M, Pilepich MV, Roach M 3rd, Wolkov HB, Sause WT, et al. Early initiation of salvage hormone therapy influences survival in patients who failed initial radiation for locally advanced prostate cancer: a secondary analysis of RTOG protocol 86-10. Int J Radiat Oncol Biol Phys. 2006;64(4):1162–7.
https://doi.org/10.1016/j.ijrobp.2005.09.039
.